Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections

Clinical trial NCT05799716 · UNKNOWN

Trial details

NCT number: NCT05799716
Sponsor: Shanghai Changzheng Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Viremia Bacteremia Acute Rejection of Renal Transplant

Start date: 2023-04-01
Primary completion: 2024-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.